When was Pinnacle Medicines founded?

Pinnacle Medicines was founded in 2024 and raised its 1st funding round 2 years after it was founded.

How many employees does Pinnacle Medicines have?

As of Sep 30, 2026, the latest employee count at Pinnacle Medicines is 23.

Is Pinnacle Medicines a funded company?

Pinnacle Medicines is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Mar 26, 2026.

When was the latest funding round of Pinnacle Medicines?

Pinnacle Medicines' latest funding was a $***** Series B round on Mar 26, 2026, with participation from 7 investors.

Where does Pinnacle Medicines rank among its competitors?

Pinnacle Medicines ranks 190th amongst 2103 active competitors, of which 115 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Pinnacle Medicines, which secured $89M in Mar, 2026.

Who are the top competitors of Pinnacle Medicines?

Pinnacle Medicines' top competitors include AbbVie, Merck and Gilead. Among them, Pinnacle Medicines secured the most recent funding round in March, 2026.

Pinnacle Medicines - 2026 Company Profile, Funding & Competitors

Company Details

Developer of peptide therapeutics addressing unmet medical needs with safe options. The company focuses on discovering first-in-class and best-in-class peptide therapeutics. It utilizes expertise in peptide drug discovery and structure-based design tools. The goal is to realize the potential of peptide modality for effective treatments.

Key Metrics

Founded Year

2024

Stage

Series B

Total Funding

$134M in 1 round

Latest Funding Round

Series B, Mar 26, 2026, $*****

Investors

Foresite Capital & 6 more

Ranked

190^th among 2103 active competitors

Employee Count

23 as on Sep 30, 2026

Similar Companies

AbbVie & 2133 more

View Pinnacle Medicines' full profile

Pinnacle Medicines has raised a total funding of $134M over 1 round. Its latest funding round was a Series B round on Mar 26, 2026 for $*****. 7 investors participated in its latest round. Pinnacle Medicines has 7 institutional investors.

Here is the list of recent funding rounds of Pinnacle Medicines:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 26, 2026	2108068	Series B	8954006	9259268	3577502	5828690

Access funding benchmarks and valuations. Sign up today!

View details of Pinnacle Medicines's funding rounds and investors

Pinnacle Medicines' employee count trend

Pinnacle Medicines has 23 employees as of Sep 26. Here is Pinnacle Medicines's employee count trend over the years:

Employee count trend for Pinnacle Medicines

Uncover Pinnacle Medicines' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pinnacle Medicines include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of Pinnacle Medicines, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	84/100
2nd	Merck 1891, Rahway (United States), Public	Manufacturer of pharmaceutical products	-	Bill & Melinda Gates Foundation, Berkshire Hathaway ... & 11 others	83/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 18 others	82/100
4th	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	80/100
5th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	77/100
6th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	76/100
7th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 17 others	76/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	72/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Mulhacen Holding, Gilde Healthcare & 12 others	71/100
10th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Berkshire Hathaway, Alcor Fund & 16 others	71/100
190th	Pinnacle Medicines 2024, Series B	Developer of peptide therapeutics addressing unmet medical needs with safe options	$134M	Foresite Capital, RA Capital Management & 5 others	40/100